Host: Prathima Setty, MD

Guest: Mitchell Cairo, MD

The goal of this program is to increase the knowledge and understanding of healthcare providers involved in the care of cancer patients at risk for tumor lysis syndrome (TLS). This interview with renowned expert, Dr. Mitchell Cairo, will focus on a comprehensive TLS risk classification system developed by an international TLS expert consensus panel. TLS is a potentially serious and life-threatening consequence of the successful treatment of various malignancies resulting from massive tumor cell lysis. The best way to manage this condition is through prevention, however the risk for TLS is often underestimated by many clinicians. TLS usually occurs in rapidly proliferating hematologic cancers, however with new advances seen in cancer treatment on a regular basis, the incidence of TLS may increase and may also arise in a broader spectrum of malignancies. As a result, clinicians will likely see an increased number of cancer patients presenting with TLS in their practice. This oncologic emergency requires immediate intervention. As TLS is potentially fatal if not recognized and promptly treated, it is essential to identify patients at risk. Prevention of TLS depends on heightened awareness, accurate assessment of risk factors, and risk-based management. This expert interview is accompanied by a downloadable clinical ...